Rosen Comments on Implications of Delay on Passing FDARA

25 July 2017 Pink Sheet News

Partner David Rosen told Pink Sheet in an article, “FDA Gives Congress Reprieve on Deadline for Passing User Fee Bill,” that most Senators are still pushing to get the FDA Reauthorization Act done prior to October 1, 2017.

FDA Commissioner Gottlieb recently sent a memo to all FDA employees that it does not plan to send reduction in force notices on August 1, 2017 to employees that could lose their jobs if FDARA is not enacted by October 1, 2017. “Gottlieb would not be telling employees about his plans unless the agency was "comfortable that they have assurances that the bill is going to pass,” Rosen said.

(Subscription required to read)

Related Services


European Data Protection Board Issues Recommendations for Exports of Personal Data From the European Economic Area
01 December 2020
Privacy, Cybersecurity & Technology Law Perspectives
Podcast Episode 24: Steve Cade, Partner
01 December 2020
Foley Career Perspectives
U.S. Companies Must Prepare to Pay Higher Wages for Specialty Occupation Foreign Workers
30 November 2020
Labor & Employment Law Perspectives
A Shield for Employers: State COVID-19 Indemnity Laws
30 November 2020
Coronavirus Resource Center:Back to Business
HCCA San Francisco Regional Conference
04 December 2020
Virtual Conference
Webinar: Massachusetts Paid Family and Medical Leave 2021
02 December 2020
CTeL Digital Health Summit 2020
01-04 December 2020
Virtual Conference
Virtual CLE Week
Every Tuesday & Thursday from December 1 - 17 2020